Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study

İsmail Mert Vural; Kemal Gökhan Ulusoy

Makale detayları

Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study

Yazarlar:

İsmail Mert Vural | Kemal Gökhan Ulusoy

Yayıncı:

Sakarya University

Ana Başlıklar:

Sağlık Kurumları Yönetimi

Dergi:

Sakarya Tıp Dergisi Vol.13 Issue 1, pp.48-54

Belge Tipi:

Makale

Yayın Tarihi:

3/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001284724

pISSN:

2146-409X

Anahtar kelimeler:

Özet:

 This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 Glp-1 analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years. We analyzed the data before the covid-19 pandemic and made predictions based on these data. This study analyzed retail and hospital box sales of insulin preparations from 4 therapeutic categories fastshort-acting, intermediate-acting, premix, long-acting and Glp-1 analogs. Total box sales of the insulin preparations were increased by 13,30 in the period examined. While fastshort-acting and long-acting insulin box sales increased with a decreasing upward trend, intermediate-acting and premix insulin box sales decreased. Glp-1 analog sales increased rapidly in this period. Currently, newer pharmaceuticals have been entering Turkish market for diabetes treatment. Less insulin might be required if newer pharmaceuticals are more widely available in diabetes treatment. Also it will be useful to evaluate the effect of the pandemic on access to pharmaceuticals used in the treatment of chronic diseases in future studies.

 This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 Glp-1 analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years. We analyzed the data before the covid-19 pandemic and made predictions based on these data. This study analyzed retail and hospital box sales of insulin preparations from 4 therapeutic categories fastshort-acting, intermediate-acting, premix, long-acting and Glp-1 analogs. Total box sales of the insulin preparations were increased by 13,30 in the period examined. While fastshort-acting and long-acting insulin box sales increased with a decreasing upward trend, intermediate-acting and premix insulin box sales decreased. Glp-1 analog sales increased rapidly in this period. Currently, newer pharmaceuticals have been entering Turkish market for diabetes treatment. Less insulin might be required if newer pharmaceuticals are more widely available in diabetes treatment. Also it will be useful to evaluate the effect of the pandemic on access to pharmaceuticals used in the treatment of chronic diseases in future studies.

 This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 Glp-1 analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years. We analyzed the data before the covid-19 pandemic and made predictions based on these data. This study analyzed retail and hospital box sales of insulin preparations from 4 therapeutic categories fastshort-acting, intermediate-acting, premix, long-acting and Glp-1 analogs. Total box sales of the insulin preparations were increased by 13,30 in the period examined. While fastshort-acting and long-acting insulin box sales increased with a decreasing upward trend, intermediate-acting and premix insulin box sales decreased. Glp-1 analog sales increased rapidly in this period. Currently, newer pharmaceuticals have been entering Turkish market for diabetes treatment. Less insulin might be required if newer pharmaceuticals are more widely available in diabetes treatment. Also it will be useful to evaluate the effect of the pandemic on access to pharmaceuticals used in the treatment of chronic diseases in future studies.

 Bu çalışmada, Türkiyedeki insülin preparatları ve glukagon benzeri peptid-1 Glp-1 analoglarının terapötik kategorilerine göre kutu satış trendlerini değerlendirmek amaçlanmıştır. Ayrıca bu ilaçların önümüzdeki yıllardaki satış trendlerini de yansıtılması hedeflenmiştir. Covid-19 pandemisi öncesi verileri analiz edilmiş ve bu verilere dayanarak tahminlerde bulunulmuştur. Bu çalışmada, 4 terapötik gruptaki insülin preparatlarının hızlıkısa etkili, orta etkili, premiks, uzun etkili ve Glp-1 analoglarının perakende ve hastane kutu satışlarını analiz edilmiştir. İncelenen dönemde insülin preparatlarının toplam kutu satışlarının 13,30 oranında arttığı saptanmıştır. Hızlıkısa etkili ve uzun etkili insülin kutusu satışları azalan artış trendi ile artarken, orta etkili ve premiks insülin kutu satışları azalmıştır. Glp-1 analog satışları bu dönemde hızla artmıştır. Diyabet tedavisi için Türkiye pazarına yeni ilaç grupları ve etken maddeler girmektedir. Bu yeni ilaçların diyabet tedavisinde daha yaygın olarak kullanılması daha az insülin kullanımına neden olabilir. Ayrıca gelecekte yapılacak çalışmalarda pandeminin kronik hastalıkların tedavisinde kullanılan ilaçlara erişim üzerindeki etkisinin değerlendirilmesi faydalı olacaktır.

Makale detayları

Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study

Yazarlar:

İsmail Mert Vural | Kemal Gökhan Ulusoy

Yayıncı:

Sakarya University

Ana Başlıklar:

Sağlık Kurumları Yönetimi

Dergi:

Sakarya Tıp Dergisi Vol.13 Issue 1, pp.48-54

Belge Tipi:

Makale

Yayın Tarihi:

3/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001284724

pISSN:

2146-409X

Diabetes mellitus

Insulin sales

Glucagon-like peptide-1 analog sales

Diyabetes Mellitüs

İnsülin satışları

; Glukagon benzeri peptid-1 analog satışları

Sayı

Makale detayları

Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study

Yazarlar: İsmail Mert Vural | Kemal Gökhan Ulusoy

Yayıncı: Sakarya University

Ana Başlıklar: Sağlık Kurumları Yönetimi

Dergi: Sakarya Tıp Dergisi Vol.13 Issue 1, pp.48-54

Belge Tipi: Makale

Yayın Tarihi: 3/2023

Belge Dili: İngilizce

Document ID (Org No.): 2001284724

pISSN: 2146-409X

Diabetes mellitus

Insulin sales

Glucagon-like peptide-1 analog sales

Diyabetes Mellitüs

İnsülin satışları

; Glukagon benzeri peptid-1 analog satışları

Sayı

Yazarlar:

İsmail Mert Vural | Kemal Gökhan Ulusoy

Yayıncı:

Sakarya University

Ana Başlıklar:

Sağlık Kurumları Yönetimi

Dergi:

Sakarya Tıp Dergisi Vol.13 Issue 1, pp.48-54

Belge Tipi:

Makale

Yayın Tarihi:

3/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001284724

pISSN:

2146-409X